Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130

doi:10.1084/jem.179.4.1337

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Zhang, X. G.
	Articles by Bataille, R.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Zhang, X. G.
	Articles by Bataille, R.


Social Bookmarking

	What's this?

ARTICLES

Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130

XG Zhang, JJ Gu, ZY Lu, K Yasukawa, GD Yancopoulos, K Turner, M Shoyab, T Taga, T Kishimoto and R Bataille
Institute for Molecular Genetics, CNRS BP5051, Montepellier, France.

Interleukin 6 (IL-6) is a major growth factor for tumor plasma cells involved in human multiple myeloma (MM). In particular, human myeloma cell lines (HMCL), whose growth is completely dependent on addition of exogenous IL-6, can be obtained reproducibly from every patient with terminal disease. Four cytokines, ciliary neurotropic factor (CNTF), IL- 11, leukemia inhibitory factor (LIF), and oncostatin M (OM), use the same transducer chain (signal transducer gp130) as IL-6 and share numerous biological activities with this IL. We found that these four cytokines stimulated proliferation and supported the long-term growth of two out of four IL-6-dependent HMCL obtained in our laboratory. Half- maximal proliferation was obtained with cytokine concentrations ranging from 0.4 to 1.2 ng/ml for IL-11, LIF, and OM. CNTF worked at high concentrations only (90 ng/ml), but addition of soluble CNTF receptor increased sensitivity to CNTF 30-fold. The growth-promoting effect of these four cytokines was abrogated by anti-gp130 antibodies, contrary to results for anti-IL-6 receptor or anti-IL-6 antibodies. No detectable changes in the morphology and phenotype were found when myeloma cells were cultured with one of these four cytokines instead of IL-6. Concordant with their IL-6-dependent growth, the four HMCL expressed membrane IL-6R and gp130 detected by FACS analysis. LIF- binding chain gene (LIFR) was expressed only in the two HMCL responsive to LIF and OM.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Abroun, S., Ishikawa, H., Tsuyama, N., Liu, S., Li, F.-J., Otsuyama, K.-i., Zheng, X., Obata, M., Kawano, M. M. (2004). Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in myeloma cells that highly express IL-6 receptor {alpha}. Blood 103: 2291-2298 [Abstract] [Full Text]
Kiessling, S., Muller-Newen, G., Leeb, S. N., Hausmann, M., Rath, H. C., Strater, J., Spottl, T., Schlottmann, K., Grossmann, J., Montero-Julian, F. A., Scholmerich, J., Andus, T., Buschauer, A., Heinrich, P. C., Rogler, G. (2004). Functional Expression of the Interleukin-11 Receptor {alpha}-Chain and Evidence of Antiapoptotic Effects in Human Colonic Epithelial Cells. J. Biol. Chem. 279: 10304-10315 [Abstract] [Full Text]
Abbud, R. A., Kelleher, R., Melmed, S. (2004). Cell-Specific Pituitary Gene Expression Profiles after Treatment with Leukemia Inhibitory Factor Reveal Novel Modulators for Proopiomelanocortin Expression. Endocrinology 145: 867-880 [Abstract] [Full Text]
Trikha, M., Corringham, R., Klein, B., Rossi, J.-F. (2003). Targeted Anti-Interleukin-6 Monoclonal Antibody Therapy for Cancer: A Review of the Rationale and Clinical Evidence. Clin. Cancer Res. 9: 4653-4665 [Abstract] [Full Text]
Underhill-Day, N., McGovern, L. A., Karpovich, N., Mardon, H. J., Barton, V. A., Heath, J. K. (2003). Functional Characterization of W147A: A High-Affinity Interleukin-11 Antagonist. Endocrinology 144: 3406-3414 [Abstract] [Full Text]
Laszlo, G. S., Nathanson, N. M. (2003). Src Family Kinase-independent Signal Transduction and Gene Induction by Leukemia Inhibitory Factor. J. Biol. Chem. 278: 27750-27757 [Abstract] [Full Text]
Wang, Y.-D., Gu, Z.-J., Huang, J.-A., Zhu, Y.-B., Zhou, Z.-H., Xie, W., Xu, Y., Qiu, Y.-H., Zhang, X.-G. (2002). gp130-linked signal transduction promotes the differentiation and maturation of dendritic cells. Int Immunol 14: 599-603 [Abstract] [Full Text]
Hutt, J. A., DeWille, J. W. (2002). Oncostatin M Induces Growth Arrest of Mammary Epithelium via a CCAAT/enhancer-binding Protein {delta}-dependent Pathway. Molecular Cancer Therapeutics 1: 601-610 [Abstract] [Full Text]
Ohata, Y., Harada, T., Fujii, A., Yoshida, S., Iwabe, T., Terakawa, N. (2001). Menstrual cycle-specific inhibition of endometrial stromal cell proliferation by oncostatin M. Mol Hum Reprod 7: 665-670 [Abstract] [Full Text]
Li, W. Q., Dehnade, F., Zafarullah, M. (2001). Oncostatin M-Induced Matrix Metalloproteinase and Tissue Inhibitor of Metalloproteinase-3 Genes Expression in Chondrocytes Requires Janus Kinase/STAT Signaling Pathway. J. Immunol. 166: 3491-3498 [Abstract] [Full Text]
Nishibe, T., Parry, G., Ishida, A., Aziz, S., Murray, J., Patel, Y., Rahman, S., Strand, K., Saito, K., Saito, Y., Hammond, W. P., Savidge, G. F., Mackman, N., Wijelath, E. S. (2001). Oncostatin M promotes biphasic tissue factor expression in smooth muscle cells: evidence for Erk-1/2 activation. Blood 97: 692-699 [Abstract] [Full Text]
Rawstron, A. C., Fenton, J. A. L., Ashcroft, J., English, A., Jones, R. A., Richards, S. J., Pratt, G., Owen, R., Davies, F. E., Child, J. A., Jack, A. S., Morgan, G. (2000). The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells. Blood 96: 3880-3886 [Abstract] [Full Text]
Rawat, R., Rainey, G. J., Thompson, C. D., Frazier-Jessen, M. R., Brown, R. T., Nordan, R. P. (2000). Constitutive activation of STAT3 is associated with the acquisition of an interleukin 6-independent phenotype by murine plasmacytomas and hybridomas. Blood 96: 3514-3521 [Abstract] [Full Text]
Ihn, H., Tamaki, K. (2000). Oncostatin M Stimulates the Growth of Dermal Fibroblasts Via a Mitogen-Activated Protein Kinase-Dependent Pathway. J. Immunol. 165: 2149-2155 [Abstract] [Full Text]
Ogawa, M., Nishiura, T., Oritani, K., Yoshida, H., Yoshimura, M., Okajima, Y., Ishikawa, J., Hashimoto, K., Matsumura, I., Tomiyama, Y., Matsuzawa, Y. (2000). Cytokines Prevent Dexamethasone-induced Apoptosis via the Activation of Mitogen-activated Protein Kinase and Phosphatidylinositol 3-Kinase Pathways in a New Multiple Myeloma Cell Line. Cancer Res. 60: 4262-4269 [Abstract] [Full Text]
Auernhammer, C. J., Melmed, S. (2000). Leukemia-Inhibitory Factor--Neuroimmune Modulator of Endocrine Function. Endocr. Rev. 21: 313-345 [Abstract] [Full Text]
Mahboubi, K., Biedermann, B. C., Carroll, J. M., Pober, J. S. (2000). IL-11 Activates Human Endothelial Cells to Resist Immune-Mediated Injury. J. Immunol. 164: 3837-3846 [Abstract] [Full Text]
Sjin, R. M. T. T., Lord, K. A., Abdollahi, A., Hoffman, B., Liebermann, D. A. (1999). Interleukin-6 and Leukemia Inhibitory Factor Induction of JunB Is Regulated by Distinct Cell Type-specific Cis-acting Elements. J. Biol. Chem. 274: 28697-28707 [Abstract] [Full Text]
Blanchard, F., Duplomb, L., Raher, S., Vusio, P., Hoflack, B., Jacques, Y., Godard, A. (1999). Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Mediates Internalization and Degradation of Leukemia Inhibitory Factor but Not Signal Transduction. J. Biol. Chem. 274: 24685-24693 [Abstract] [Full Text]
Reznikov, L. L., Puren, A. J., Fantuzzi, G., Hamner, G. R., Schwertschlag, U. S., Ryan, J. L., Dinarello, C. A. (1999). Suppression of endotoxin-inducible cytokines in whole blood from human subjects following single dose of recombinant human interleukin-11. Innate Immunity 5: 197-204 [Abstract]
Kiuchi, N., Nakajima, K., Ichiba, M., Fukada, T., Narimatsu, M., Mizuno, K., Hibi, M., Hirano, T. (1999). STAT3 Is Required for the gp130-mediated Full Activation of the c-myc Gene. J. Exp. Med. 189: 63-73 [Abstract] [Full Text]
Renne, C., Kallen, K.-J., Mullberg, J., Jostock, T., Grotzinger, J., Rose-John, S. (1998). A New Type of Cytokine Receptor Antagonist Directly Targeting gp130. J. Biol. Chem. 273: 27213-27219 [Abstract] [Full Text]
Ferlin-Bezombes, M., Jourdan, M., Liautard, J., Brochier, J., Rossi, J.-F., Klein, B. (1998). IFN-{alpha} Is a Survival Factor for Human Myeloma Cells and Reduces Dexamethasone-Induced Apoptosis. J. Immunol. 161: 2692-2699 [Abstract] [Full Text]
Hallek, M., Leif Bergsagel, P., Anderson, K. C. (1998). Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process. Blood 91: 3-21 [Full Text]
Vernallis, A. B., Hudson, K. R., Heath, J. K. (1997). An Antagonist for the Leukemia Inhibitory Factor Receptor Inhibits Leukemia Inhibitory Factor, Cardiotrophin-1, Ciliary Neurotrophic Factor, and Oncostatin M. J. Biol. Chem. 272: 26947-26952 [Abstract] [Full Text]
Ihn, H., LeRoy, E. C., Trojanowska, M. (1997). Oncostatin M Stimulates Transcription of the Human alpha 2(I) Collagen Gene via the Sp1/Sp3-binding Site. J. Biol. Chem. 272: 24666-24672 [Abstract] [Full Text]
Du, X., Williams, D. A. (1997). Interleukin-11: Review of Molecular, Cell Biology, and Clinical Use. Blood 89: 3897-3908 [Full Text]
Wijelath, E., Carlsen, B, Cole, T, Chen, J, Kothari, S, Hammond, W. (1997). Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology. J. Cell Sci. 110: 871-879 [Abstract]